Traders work on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Friday, Feb. 1, 2013. Zoetis Inc., the animal-health company owned by Pfizer Inc., surged as much as 22 percent in its debut after raising $2.24 billion in its initial public offering, pricing the shares above the proposed price range. Photographer: Jin Lee/Bloomberg via Getty Images
{"Image ImageDescription": "Traders work on the floor of the New York Stock Exchange (NYSE) in New York, U.S., on Friday, Feb. 1, 2013. Zoetis Inc., the animal-health company owned by Pfizer Inc., surged as much as 22 percent in its debut after raising $2.24 billion in its initial public offering, pricing the shares above the proposed price range. Photographer: Jin Lee/Bloomberg via Getty Images", "Image Copyright": "2013 Bloomberg"}